Good adherence and early efficacy using desonide hydrogel for atopic dermatitis: Results from a program addressing patient compliance

Journal of Drugs in Dermatology

Volumn 9, Issue 4, 2010, Pages 324-329

  Yentzer, Brad A ^a   Camacho, Fabian T ^b   Young, Trudye ^a   Fountain, Julie M ^a   Clark, Adele R ^a   Feldman, Steven R ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DERMA SMOOTHE; DESONIDE; FLUOCINOLONE ACETONIDE; HYDROCORTISONE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; ATOPIC DERMATITIS; CHILD; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; CREAM; DISEASE SEVERITY; DRUG EFFICACY; DRUG FORMULATION; FEMALE; FOLLOW UP; HEALTH SURVEY; HUMAN; HYDROGEL; HYPOPIGMENTATION; INFANT; LOTION; MALE; MONITOR; OINTMENT; PATIENT COMPLIANCE; PRESCHOOL CHILD; PRURITUS; SCHOOL CHILD; MIDDLE AGED;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; DERMATITIS, ATOPIC; DESONIDE; FEMALE; HUMANS; HYDROGEL; INFANT; MALE; MEDICATION ADHERENCE; MIDDLE AGED;

EID: 77953637979     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Lee C, Koo J. Papulosquamous Disorders. In: Rakel R, Bope E, Conn H, editors. Conn's Current Therapy 2008. Philadelphia, PA; Elsevier Saunders. 2007:789-793.
2. Gans EH, Sadiq I, Stoudemayer T, et al. In vivo determination of the skin atrophy potential of the super-high-potency topical corticosteroid fluocinonide 0.1% cream compared with clobetasol propionate 0.05% cream and foam, and a vehicle. J Drugs Dermatol. 2008;7(1):28-32.
3. Hebert AA, Cook-Bolden FE, Basu S, et al. Safety and efficacy of desonide hydrogel 0.05% in pediatric subjects with atopic dermatitis. J Drugs Dermatol. 2007;6(2):175-181.
4. Krejci-Manwaring J, Tusa MG, Carroll C, et al. Stealth monitoring of adherence to topical medication: Adherence is very poor in children with atopic dermatitis. J Am Acad Dermatol. 2007;56(2):211-216. (Pubitemid 46074250)
5. Ali SM, Brodell RT, Balkrishnan R, Feldman SR. Poor adherence to treatments: A fundamental principle of dermatology. Arch Dermatol. 2007;143(7):912-915. (Pubitemid 47076491)
6. Balkrishnan R. The importance of medication adherence in improving chronic-disease related outcomes: What we know and what we need to further know. Med Care. 2005;43(6):517-520. (Pubitemid 40847287)
7. Brown KK, Rehmus WE, Kimball AB. Determining the relative importance of patient motivations for nonadherence to topical corticosteroid therapy in psoriasis. J Am Acad Dermatol. 2006;55(4):607-613. (Pubitemid 44436629)
8. Carroll CL, Feldman SR, Camacho FT, et al. Adherence to topical therapy decreases during the course of an eight-week psoriasis clinical trial: Commonly used methods of measuring adherence to topical therapy overestimate actual use. J Am Acad Dermatol. 2004;51(2):212-216.
9. Feldman SR, Camacho FT, Krejci-Manwaring J, et al. Adherence to topical therapy increases around the time of office visits. J Am Acad Dermatol. 2007;57(1):81-83. (Pubitemid 46908856)
10. Koehler AM, Maibach HI. Electronic monitoring in medication adherence measurement. Implications for dermatology. Am J Clin Dermatol. 2001;2(1):7-12.
11. Krejci-Manwaring J, McCarty MA, Camacho F, et al. Adherence with topical treatment is poor compared with adherence with oral agents: Implications for effective clinical use of topical agents. J Am Acad Dermatol. 2006;54(5 Suppl):S235-S236.
12. Jorizzo J, Levy M, Lucky A, et al. Multicenter trial for long-term safety and efficacy comparison of 0.05% desonide and 1% hydrocortisone ointments in the treatment of atopic dermatitis in pediatric patients. J Am Acad Dermatol. 1995;33(1):74-77.
13. Cornell RC, Baker MD. Dermal safety comparison of 0.05% desonide cream and 1.0-percent hydrocortisone cream. Curr Ther Re-Clin Exper. 1993;53:356-359. (Pubitemid 23234693)
14. Feinstein AR. On white-coat effects and the electronic monitoring of compliance. Arch Intern Med. 1990;150(7):1377-1378. (Pubitemid 20215672)
15. Hanifin JM, Thurston M, Omoto M, et al. The eczema area and severity index (EASI): Assessment of reliability in atopic dermatitis. EASI Evaluator Group. Exp Dermatol. 2001;10(1):11-18. (Pubitemid 32098039)
16. Feldman SR, Housman TS. Patients' vehicle preference for corticosteroid treatments of scalp psoriasis. Am J Clin Dermatol. 2003;4(4):221-224. (Pubitemid 36506427)
17. Cork MJ, Britton J, Butler L, et al. Comparison of parent knowledge, therapy utilization and severity of atopic eczema before and after explanation and demonstration of topical therapies by a specialist dermatology nurse. Br J Dermatol. 2003;149(3):582-589. (Pubitemid 37281592)